Wall Street Zen cut shares of Zepp Health (NYSE:ZEPP – Free Report) from a hold rating to a sell rating in a report released on Sunday.
Separately, Fundamental Research set a $56.28 price target on Zepp Health and gave the company a “buy” rating in a research report on Wednesday, April 22nd. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $56.28.
View Our Latest Stock Report on ZEPP
Zepp Health Trading Up 0.7%
Insiders Place Their Bets
In related news, CFO Cheng Deng sold 9,836 shares of the stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $4.61, for a total transaction of $45,343.96. Following the sale, the chief financial officer owned 114,539 shares in the company, valued at $528,024.79. This represents a 7.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 36.00% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Zepp Health
Institutional investors have recently made changes to their positions in the stock. Public Employees Retirement System of Ohio lifted its holdings in shares of Zepp Health by 61.4% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,514 shares of the company’s stock worth $41,000 after purchasing an additional 576 shares during the last quarter. Harvest Fund Management Co. Ltd boosted its position in Zepp Health by 6.7% during the 4th quarter. Harvest Fund Management Co. Ltd now owns 44,800 shares of the company’s stock valued at $1,207,000 after purchasing an additional 2,800 shares during the period. Osaic Holdings Inc. grew its stake in Zepp Health by 239.5% during the 4th quarter. Osaic Holdings Inc. now owns 8,285 shares of the company’s stock worth $223,000 after buying an additional 5,845 shares during the last quarter. Dimensional Fund Advisors LP acquired a new stake in Zepp Health in the fourth quarter worth $241,000. Finally, Capstone Capital Management Ltd acquired a new stake in Zepp Health in the fourth quarter worth $298,000. 52.61% of the stock is owned by institutional investors.
Zepp Health Company Profile
Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.
At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.
Further Reading
- Five stocks we like better than Zepp Health
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Receive News & Ratings for Zepp Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zepp Health and related companies with MarketBeat.com's FREE daily email newsletter.
